HSBC Holdings’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.9K | Buy |
+26,075
| New | +$55.9K | ﹤0.01% | 2444 |
|
|
2022
Q3 | – | Sell |
-3,533
| Closed | -$73K | – | 2603 |
|
|
2022
Q2 | $73K | Sell |
3,533
-440
| -11% | -$9.09K | ﹤0.01% | 2652 |
|
|
2022
Q1 | $171K | Buy |
3,973
+540
| +16% | +$23.2K | ﹤0.01% | 2646 |
|
|
2021
Q4 | $206K | Hold |
3,433
| – | – | ﹤0.01% | 2538 |
|
|
2021
Q3 | $295K | Sell |
3,433
-1,020
| -23% | -$87.6K | ﹤0.01% | 2102 |
|
|
2021
Q2 | $497K | Buy |
4,453
+995
| +29% | +$111K | ﹤0.01% | 1782 |
|
|
2021
Q1 | $385K | Sell |
3,458
-1,255
| -27% | -$140K | ﹤0.01% | 1806 |
|
|
2020
Q4 | $502K | Buy |
4,713
+3,535
| +300% | +$377K | ﹤0.01% | 1790 |
|
|
2020
Q3 | $164K | Sell |
1,178
-90
| -7% | -$12.5K | ﹤0.01% | 2086 |
|
|
2020
Q2 | $410K | Buy |
+1,268
| New | +$410K | ﹤0.01% | 1606 |
|
|
2017
Q1 | – | Sell |
-953
| Closed | -$79K | – | 1876 |
|
|
2016
Q4 | $79K | Buy |
+953
| New | +$79K | ﹤0.01% | 2192 |
|